Correlation Between Edgewise Therapeutics and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Ventyx Biosciences, you can compare the effects of market volatilities on Edgewise Therapeutics and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Ventyx Biosciences.
Diversification Opportunities for Edgewise Therapeutics and Ventyx Biosciences
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Ventyx is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Ventyx Biosciences
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.69 times more return on investment than Ventyx Biosciences. However, Edgewise Therapeutics is 1.44 times less risky than Ventyx Biosciences. It trades about 0.08 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about -0.04 per unit of risk. If you would invest 678.00 in Edgewise Therapeutics on December 12, 2024 and sell it today you would earn a total of 1,978 from holding Edgewise Therapeutics or generate 291.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Ventyx Biosciences
Performance |
| Timeline |
| Edgewise Therapeutics |
| Ventyx Biosciences |
Edgewise Therapeutics and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Ventyx Biosciences
The main advantage of trading using opposite Edgewise Therapeutics and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.| Edgewise Therapeutics vs. Century Therapeutics | ||
| Edgewise Therapeutics vs. C4 Therapeutics | ||
| Edgewise Therapeutics vs. Mineralys Therapeutics, Common | ||
| Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Ventyx Biosciences vs. Arcellx | ||
| Ventyx Biosciences vs. Immunocore Holdings | ||
| Ventyx Biosciences vs. Vaxcyte | ||
| Ventyx Biosciences vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |